Ian A. Critchley
Replidyne Inc.
1450 Infinite Drive
Louisville
CO 80027
USA
Name/email consistency: high
- Prevalence of serotype 19A Streptococcus pneumoniae among isolates from U.S. children in 2005-2006 and activity of faropenem. Critchley, I.A., Jacobs, M.R., Brown, S.D., Traczewski, M.M., Tillotson, G.S., Janjic, N. Antimicrob. Agents Chemother. (2008)
- Recent advances in the preclinical evaluation of the topical antibacterial agent REP8839. Critchley, I.A., Ochsner, U.A. Curr. Opin. Chem. Biol (2008)
- National and regional assessment of antimicrobial resistance among community-acquired respiratory tract pathogens identified in a 2005-2006 U.S. Faropenem surveillance study. Critchley, I.A., Brown, S.D., Traczewski, M.M., Tillotson, G.S., Janjic, N. Antimicrob. Agents Chemother. (2007)
- Antibacterial activity of REP8839, a new antibiotic for topical use. Critchley, I.A., Young, C.L., Stone, K.C., Ochsner, U.A., Guiles, J., Tarasow, T., Janjic, N. Antimicrob. Agents Chemother. (2005)
- Optimal use of antibiotic resistance surveillance systems. Critchley, I.A., Karlowsky, J.A. Clin. Microbiol. Infect. (2004)